PLoS ONE, ISSN 1932-6203, 06/2012, Volume 7, Issue 6, p. e40015
The relationship between benign uterine leiomyomas and their malignant counterparts, i.e. leiomyosarcomas and smooth muscle tumors of uncertain malignant...
NEOPLASMS | LEIOMYOSARCOMA | LEIOMYOMA | MEDIATOR | MULTIDISCIPLINARY SCIENCES | X-CHROMOSOME INACTIVATION | BROAD LIGAMENT | COMPARATIVE GENOMIC HYBRIDIZATION | ABERRATIONS | BETA-CATENIN EXPRESSION | CLONAL ORIGINS | Mediator Complex - metabolism | Uterine Neoplasms - pathology | Humans | DNA, Complementary - genetics | Gene Expression Regulation, Neoplastic | Molecular Sequence Data | Leiomyoma - pathology | Smooth Muscle Tumor - genetics | Cell Transformation, Neoplastic - genetics | DNA Mutational Analysis | Base Sequence | Female | Soft Tissue Neoplasms - genetics | Uterine Neoplasms - genetics | Mediator Complex - genetics | Smooth Muscle Tumor - pathology | Mutation - genetics | beta Catenin - metabolism | Genome, Human - genetics | Protein Transport | Wnt Signaling Pathway - genetics | Alleles | Soft Tissue Neoplasms - pathology | Cell Transformation, Neoplastic - pathology | Leiomyoma - genetics | Immunohistochemistry | Development and progression | Gene mutations | Cancer | Wnt protein | Mesenchyme | Smooth muscle | Subgroups | β-catenin | Alterations | Uterus | Genetics | Tumorigenesis | Localization | Deoxyribonucleic acid--DNA | Sequences | Hot spots | Benign | Muscles | Fibroids | Breast cancer | RNA polymerase | Gene expression | Pathology | MicroRNAs | Pancreatic cancer | Mutation | Tumors | Deoxyribonucleic acid | DNA
NEOPLASMS | LEIOMYOSARCOMA | LEIOMYOMA | MEDIATOR | MULTIDISCIPLINARY SCIENCES | X-CHROMOSOME INACTIVATION | BROAD LIGAMENT | COMPARATIVE GENOMIC HYBRIDIZATION | ABERRATIONS | BETA-CATENIN EXPRESSION | CLONAL ORIGINS | Mediator Complex - metabolism | Uterine Neoplasms - pathology | Humans | DNA, Complementary - genetics | Gene Expression Regulation, Neoplastic | Molecular Sequence Data | Leiomyoma - pathology | Smooth Muscle Tumor - genetics | Cell Transformation, Neoplastic - genetics | DNA Mutational Analysis | Base Sequence | Female | Soft Tissue Neoplasms - genetics | Uterine Neoplasms - genetics | Mediator Complex - genetics | Smooth Muscle Tumor - pathology | Mutation - genetics | beta Catenin - metabolism | Genome, Human - genetics | Protein Transport | Wnt Signaling Pathway - genetics | Alleles | Soft Tissue Neoplasms - pathology | Cell Transformation, Neoplastic - pathology | Leiomyoma - genetics | Immunohistochemistry | Development and progression | Gene mutations | Cancer | Wnt protein | Mesenchyme | Smooth muscle | Subgroups | β-catenin | Alterations | Uterus | Genetics | Tumorigenesis | Localization | Deoxyribonucleic acid--DNA | Sequences | Hot spots | Benign | Muscles | Fibroids | Breast cancer | RNA polymerase | Gene expression | Pathology | MicroRNAs | Pancreatic cancer | Mutation | Tumors | Deoxyribonucleic acid | DNA
Journal Article
Modern Pathology, ISSN 0893-3952, 12/2016, Volume 29, Issue 12, pp. 1523 - 1531
Subsets of primitive round-cell sarcomas remain difficult to diagnose and classify. Among these is a rare round cell sarcoma that harbors a CIC gene...
CIC-FOXO4 GENE FUSION | TUMOR | TRANSLOCATION | PATHOLOGY | EWING-LIKE-SARCOMA | Humans | Middle Aged | Male | Proto-Oncogene Proteins - biosynthesis | Sarcoma, Small Cell - diagnosis | Young Adult | Rhabdomyosarcoma, Alveolar - diagnosis | Proto-Oncogene Proteins - analysis | Sarcoma, Small Cell - genetics | Adenovirus E1A Proteins - biosynthesis | Aged, 80 and over | Adult | Female | Child | Sarcoma, Small Cell - pathology | Diagnosis, Differential | Biomarkers, Tumor - analysis | Repressor Proteins - genetics | Sarcoma, Ewing - diagnosis | Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Sarcoma, Synovial - diagnosis | Adenovirus E1A Proteins - analysis | Adolescent | Aged | Rhabdoid Tumor - diagnosis
CIC-FOXO4 GENE FUSION | TUMOR | TRANSLOCATION | PATHOLOGY | EWING-LIKE-SARCOMA | Humans | Middle Aged | Male | Proto-Oncogene Proteins - biosynthesis | Sarcoma, Small Cell - diagnosis | Young Adult | Rhabdomyosarcoma, Alveolar - diagnosis | Proto-Oncogene Proteins - analysis | Sarcoma, Small Cell - genetics | Adenovirus E1A Proteins - biosynthesis | Aged, 80 and over | Adult | Female | Child | Sarcoma, Small Cell - pathology | Diagnosis, Differential | Biomarkers, Tumor - analysis | Repressor Proteins - genetics | Sarcoma, Ewing - diagnosis | Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Sarcoma, Synovial - diagnosis | Adenovirus E1A Proteins - analysis | Adolescent | Aged | Rhabdoid Tumor - diagnosis
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 5, pp. 608 - 615
Purpose Synovial sarcoma (SS) occurs in both children and adults, although metastatic events are much more common in adults. Whereas the importance of the t(X;...
SSX FUSION TYPE | SOFT-TISSUE SARCOMAS | ONCOLOGY | MESSENGER-RNA EXPRESSION | GENE-EXPRESSION | KIF14 | IMBALANCES | COMPARATIVE GENOMIC HYBRIDIZATION | EPITHELIAL DIFFERENTIATION | CANCER | SYT | Oncogene Proteins - genetics | Prognosis | Sarcoma, Synovial - therapy | Humans | Gene Expression Regulation, Neoplastic | Kaplan-Meier Estimate | Male | Gene Expression Profiling | Reverse Transcriptase Polymerase Chain Reaction | DNA Copy Number Variations | Young Adult | Carrier Proteins - genetics | Sarcoma, Synovial - genetics | Adolescent | Cell Cycle Proteins - genetics | Kinesin - genetics | Adult | Female | Biomarkers, Tumor - genetics | Nuclear Proteins - genetics | Sarcoma, Synovial - pathology | Child | Chromosomal Instability | Real-Time Polymerase Chain Reaction
SSX FUSION TYPE | SOFT-TISSUE SARCOMAS | ONCOLOGY | MESSENGER-RNA EXPRESSION | GENE-EXPRESSION | KIF14 | IMBALANCES | COMPARATIVE GENOMIC HYBRIDIZATION | EPITHELIAL DIFFERENTIATION | CANCER | SYT | Oncogene Proteins - genetics | Prognosis | Sarcoma, Synovial - therapy | Humans | Gene Expression Regulation, Neoplastic | Kaplan-Meier Estimate | Male | Gene Expression Profiling | Reverse Transcriptase Polymerase Chain Reaction | DNA Copy Number Variations | Young Adult | Carrier Proteins - genetics | Sarcoma, Synovial - genetics | Adolescent | Cell Cycle Proteins - genetics | Kinesin - genetics | Adult | Female | Biomarkers, Tumor - genetics | Nuclear Proteins - genetics | Sarcoma, Synovial - pathology | Child | Chromosomal Instability | Real-Time Polymerase Chain Reaction
Journal Article
4.
Full Text
Nuclear-Receptor-Mediated Telomere Insertion Leads to Genome Instability in ALT Cancers
Cell, ISSN 0092-8674, 02/2015, Volume 160, Issue 5, pp. 913 - 927
The breakage-fusion-bridge cycle is a classical mechanism of telomere-driven genome instability in which dysfunctional telomeres are fused to other chromosomal...
ORGANIZATION | CELLS | LOCALIZATION | CHROMOSOME INSTABILITY | PROTEIN | SEQUENCES | DNA | SARCOMAS | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENE-EXPRESSION | BINDING | CELL BIOLOGY | Genomic Instability | Translocation, Genetic | Neoplasms - genetics | Humans | Receptors, N-Methyl-D-Aspartate - metabolism | Telomeric Repeat Binding Protein 2 - metabolism | Telomere - metabolism | Chromosomes, Human - metabolism | DNA Breaks, Double-Stranded | Proteins | Genetic research | Genetic aspects | Chromosomes | Genomics | Cancer | Medical research | Telomeres | Chromatin | Medicine, Experimental | Genomes | DNA binding proteins | Genetic transcription | Life Sciences | Genetics
ORGANIZATION | CELLS | LOCALIZATION | CHROMOSOME INSTABILITY | PROTEIN | SEQUENCES | DNA | SARCOMAS | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENE-EXPRESSION | BINDING | CELL BIOLOGY | Genomic Instability | Translocation, Genetic | Neoplasms - genetics | Humans | Receptors, N-Methyl-D-Aspartate - metabolism | Telomeric Repeat Binding Protein 2 - metabolism | Telomere - metabolism | Chromosomes, Human - metabolism | DNA Breaks, Double-Stranded | Proteins | Genetic research | Genetic aspects | Chromosomes | Genomics | Cancer | Medical research | Telomeres | Chromatin | Medicine, Experimental | Genomes | DNA binding proteins | Genetic transcription | Life Sciences | Genetics
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2017, Volume 23, Issue 3, pp. 857 - 867
Purpose: Despite various differences, nontranslocation-related sarcomas (e.g., comprising undifferentiated pleomorphic sarcoma, leiomyosarcoma,...
LARGE SERIES | GENE FUSIONS | SOFT-TISSUE SARCOMAS | MALIGNANT FIBROUS HISTIOCYTOMAS | ONCOLOGY | TRANSCRIPTION | RHO GTPASES | COMPARATIVE GENOMIC HYBRIDIZATION | IDENTIFICATION | EXPRESSION | TOOL | Sarcoma - classification | RNA, Small Interfering - genetics | Translocation, Genetic | Guanine Nucleotide Exchange Factors - physiology | Humans | Middle Aged | Neoplasm Proteins - physiology | Male | Telomerase - genetics | RNA Interference | Female | Telomerase - metabolism | Sarcoma - genetics | Neoplasm Proteins - genetics | Guanine Nucleotide Exchange Factors - genetics | Protein-Serine-Threonine Kinases - physiology | RNA, Messenger - genetics | Protein-Serine-Threonine Kinases - genetics | In Situ Hybridization, Fluorescence | RNA, Long Noncoding - genetics | DNA-Binding Proteins - genetics | Sarcoma - pathology | Sarcoma - metabolism | Sequence Analysis, RNA | Oncogene Proteins, Fusion - genetics | Cell Line, Tumor | RNA, Neoplasm - genetics | Aged | Protein Isoforms - genetics | Trio protein | Alternative splicing | Sarcoma | Splicing | Genes | Genomes | Gene expression | Ribonucleic acid--RNA | Immunity | Computer programs | Gene sequencing | Polymerase chain reaction | Chromosome translocations | Experimental design | Predictions | Genetics | Protein transport | Bioinformatics
LARGE SERIES | GENE FUSIONS | SOFT-TISSUE SARCOMAS | MALIGNANT FIBROUS HISTIOCYTOMAS | ONCOLOGY | TRANSCRIPTION | RHO GTPASES | COMPARATIVE GENOMIC HYBRIDIZATION | IDENTIFICATION | EXPRESSION | TOOL | Sarcoma - classification | RNA, Small Interfering - genetics | Translocation, Genetic | Guanine Nucleotide Exchange Factors - physiology | Humans | Middle Aged | Neoplasm Proteins - physiology | Male | Telomerase - genetics | RNA Interference | Female | Telomerase - metabolism | Sarcoma - genetics | Neoplasm Proteins - genetics | Guanine Nucleotide Exchange Factors - genetics | Protein-Serine-Threonine Kinases - physiology | RNA, Messenger - genetics | Protein-Serine-Threonine Kinases - genetics | In Situ Hybridization, Fluorescence | RNA, Long Noncoding - genetics | DNA-Binding Proteins - genetics | Sarcoma - pathology | Sarcoma - metabolism | Sequence Analysis, RNA | Oncogene Proteins, Fusion - genetics | Cell Line, Tumor | RNA, Neoplasm - genetics | Aged | Protein Isoforms - genetics | Trio protein | Alternative splicing | Sarcoma | Splicing | Genes | Genomes | Gene expression | Ribonucleic acid--RNA | Immunity | Computer programs | Gene sequencing | Polymerase chain reaction | Chromosome translocations | Experimental design | Predictions | Genetics | Protein transport | Bioinformatics
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2014, Volume 9, Issue 1, p. e87170
Thyroid carcinoma is the most common endocrine malignant tumor and accounts for 1% of all new malignant diseases. Among all types and subtypes of thyroid...
ALK | LUNG-CANCER | PROTEIN | MULTIDISCIPLINARY SCIENCES | GENES | PATIENT | NPM | PAPILLARY | Calmodulin-Binding Proteins - genetics | Immunohistochemistry | Pyrazoles - therapeutic use | Membrane Proteins - genetics | Humans | Thyroid Carcinoma, Anaplastic | Molecular Sequence Data | In Situ Hybridization, Fluorescence | Reverse Transcriptase Polymerase Chain Reaction | Nerve Tissue Proteins - genetics | Sequence Analysis, DNA | Gene Fusion - genetics | Thyroid Neoplasms - genetics | Comparative Genomic Hybridization | Lung Neoplasms - secondary | Receptor Protein-Tyrosine Kinases - genetics | Thyroid Neoplasms - drug therapy | Base Sequence | Gene Rearrangement - genetics | Pyridines - therapeutic use | Care and treatment | Chemotherapy | Thyroid cancer | Analysis | Genes | Cytogenetics | Lymphomas | Metastasis | Cancer | Nuclear medicine | Transcription | Lung cancer | Fluorescence | Cancer therapies | Metastases | Proteins | Surgery | Fluorescence in situ hybridization | Lesions | Protein-tyrosine kinase | Deoxyribonucleic acid--DNA | Thyroid | Iodine 131 | Lung carcinoma | Radiation therapy | Patients | Lymphoma | Polymerase chain reaction | Medical prognosis | Gene rearrangement | Hybridization analysis | Papillary thyroid carcinoma | Tumors | Deoxyribonucleic acid | DNA
ALK | LUNG-CANCER | PROTEIN | MULTIDISCIPLINARY SCIENCES | GENES | PATIENT | NPM | PAPILLARY | Calmodulin-Binding Proteins - genetics | Immunohistochemistry | Pyrazoles - therapeutic use | Membrane Proteins - genetics | Humans | Thyroid Carcinoma, Anaplastic | Molecular Sequence Data | In Situ Hybridization, Fluorescence | Reverse Transcriptase Polymerase Chain Reaction | Nerve Tissue Proteins - genetics | Sequence Analysis, DNA | Gene Fusion - genetics | Thyroid Neoplasms - genetics | Comparative Genomic Hybridization | Lung Neoplasms - secondary | Receptor Protein-Tyrosine Kinases - genetics | Thyroid Neoplasms - drug therapy | Base Sequence | Gene Rearrangement - genetics | Pyridines - therapeutic use | Care and treatment | Chemotherapy | Thyroid cancer | Analysis | Genes | Cytogenetics | Lymphomas | Metastasis | Cancer | Nuclear medicine | Transcription | Lung cancer | Fluorescence | Cancer therapies | Metastases | Proteins | Surgery | Fluorescence in situ hybridization | Lesions | Protein-tyrosine kinase | Deoxyribonucleic acid--DNA | Thyroid | Iodine 131 | Lung carcinoma | Radiation therapy | Patients | Lymphoma | Polymerase chain reaction | Medical prognosis | Gene rearrangement | Hybridization analysis | Papillary thyroid carcinoma | Tumors | Deoxyribonucleic acid | DNA
Journal Article
Cancers, ISSN 2072-6694, 01/2019, Volume 11, Issue 1, p. 81
Half of soft-tissue sarcomas are tumors with complex genomics, which display no specific genetic alterations and respond poorly to treatment. It is therefore...
Pleomorphic sarcoma | Sarcoma with complex genomics | RCBTB1 | Docetaxel | Cancer | TARGET | LIPOSARCOMA | SAFETY | sarcoma with complex genomics | PHASE-II | RANDOMIZED MULTICENTER | pleomorphic sarcoma | CHEMOTHERAPY | CHROMOSOME 13Q14 | GENE | ONCOLOGY | docetaxel | cancer | SOFT-TISSUE SARCOMA
Pleomorphic sarcoma | Sarcoma with complex genomics | RCBTB1 | Docetaxel | Cancer | TARGET | LIPOSARCOMA | SAFETY | sarcoma with complex genomics | PHASE-II | RANDOMIZED MULTICENTER | pleomorphic sarcoma | CHEMOTHERAPY | CHROMOSOME 13Q14 | GENE | ONCOLOGY | docetaxel | cancer | SOFT-TISSUE SARCOMA
Journal Article
Nucleic Acids Research, ISSN 0305-1048, 11/2018, Volume 46, Issue 19, pp. 10157 - 10172
Abstract The spatiotemporal program of metazoan DNA replication is regulated during development and altered in cancers. We have generated novel OK-seq,...
CHRONIC MYELOGENOUS LEUKEMIA | GENE | LANDSCAPE | DAMAGE-RESPONSE | PART | BIOCHEMISTRY & MOLECULAR BIOLOGY | BARRIER | MODEL | STRESS | DOMAINS | REVEALS | Life Sciences | Biochemistry, Molecular Biology | Genomics | Genome Integrity, Repair and
CHRONIC MYELOGENOUS LEUKEMIA | GENE | LANDSCAPE | DAMAGE-RESPONSE | PART | BIOCHEMISTRY & MOLECULAR BIOLOGY | BARRIER | MODEL | STRESS | DOMAINS | REVEALS | Life Sciences | Biochemistry, Molecular Biology | Genomics | Genome Integrity, Repair and
Journal Article
ONCOGENE, ISSN 0950-9232, 08/2019, Volume 38, Issue 33, pp. 6083 - 6094
Oncogenesis is considered to result from chromosomal instability, in addition to oncogene and tumor-suppressor alterations. Intermediate to aneuploidy and...
PURKINJE NEURONS | LARGE SERIES | SOFT-TISSUE SARCOMAS | METASTASIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | MUSCLE | CANCER | CELL BIOLOGY | ONCOLOGY | MARROW-DERIVED CELLS | DNA | GENETICS & HEREDITY | CONDENSATION | BONE | Aneuploidy | Development and progression | Care and treatment | Research | Carcinogenesis | Risk factors | Tetraploidy | Mesenchyme | Tumorigenesis | Genomes | Cell differentiation | Cell fusion | Tumors | Latency | Genomic instability
PURKINJE NEURONS | LARGE SERIES | SOFT-TISSUE SARCOMAS | METASTASIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | MUSCLE | CANCER | CELL BIOLOGY | ONCOLOGY | MARROW-DERIVED CELLS | DNA | GENETICS & HEREDITY | CONDENSATION | BONE | Aneuploidy | Development and progression | Care and treatment | Research | Carcinogenesis | Risk factors | Tetraploidy | Mesenchyme | Tumorigenesis | Genomes | Cell differentiation | Cell fusion | Tumors | Latency | Genomic instability
Journal Article
Modern Pathology, ISSN 0893-3952, 02/2015, Volume 28, Issue 2, pp. 230 - 237
Cytogenetically, most dermatofibrosarcoma protuberans are characterized by chromosomal rearrangements resulting in the collagen type-1 alpha 1...
REARRANGEMENT | TRANSLOCATION | RING CHROMOSOMES | GROWTH-FACTOR-B | SEQUENCES | SARCOMA | PATHOLOGY | COL1A1-PDGFB FUSION | TUMORS | EXPRESSION | IMATINIB MESYLATE | Humans | Middle Aged | Dermatofibrosarcoma - diagnosis | Child, Preschool | Infant | Male | Dermatofibrosarcoma - genetics | Oncogene Proteins, Fusion - analysis | Skin Neoplasms - diagnosis | Skin Neoplasms - genetics | Adolescent | Aged, 80 and over | Adult | Female | Aged | Biomarkers, Tumor - genetics | Child | In Situ Hybridization, Fluorescence - methods
REARRANGEMENT | TRANSLOCATION | RING CHROMOSOMES | GROWTH-FACTOR-B | SEQUENCES | SARCOMA | PATHOLOGY | COL1A1-PDGFB FUSION | TUMORS | EXPRESSION | IMATINIB MESYLATE | Humans | Middle Aged | Dermatofibrosarcoma - diagnosis | Child, Preschool | Infant | Male | Dermatofibrosarcoma - genetics | Oncogene Proteins, Fusion - analysis | Skin Neoplasms - diagnosis | Skin Neoplasms - genetics | Adolescent | Aged, 80 and over | Adult | Female | Aged | Biomarkers, Tumor - genetics | Child | In Situ Hybridization, Fluorescence - methods
Journal Article
The Journal of Pathology, ISSN 0022-3417, 01/2011, Volume 223, Issue 1, pp. 64 - 71
Adult soft tissue sarcomas (STS) are rare tumours of mesenchymal lineage. Based on cytogenetic and comparative genomic hybridization (CGH) data, they can be...
leiomyosarcoma | RB1 | CGH | transcriptome | PTEN | undifferentiated sarcoma | DKK1 | CANCER-CENTERS-SARCOMA | MYOCARDIN | TRIO | CLASSIFICATION | PATHOLOGY | LEIOMYOSARCOMAS | TUMOR-NECROSIS-FACTOR | FRENCH-FEDERATION | MALIGNANT FIBROUS HISTIOCYTOMAS | ONCOLOGY | GENE-EXPRESSION | DIFFERENTIATION | PTEN Phosphohydrolase - genetics | Leiomyosarcoma - pathology | Genomics | Humans | Middle Aged | Intercellular Signaling Peptides and Proteins - genetics | Gene Expression Profiling - methods | Male | Comparative Genomic Hybridization - methods | Sarcoma - pathology | Cell Transformation, Neoplastic - genetics | Retinoblastoma Protein - genetics | Gene Deletion | Soft Tissue Neoplasms - pathology | Leiomyosarcoma - genetics | Adult | Female | Aged | Sarcoma - genetics | Soft Tissue Neoplasms - genetics | Cluster Analysis | Mesenchyme | Sarcoma | Wnt protein | Rhabdomyosarcoma | Data processing | Gene expression | Liposarcoma | genomics | Tumorigenesis | histiocytoma | Dkk1 protein | soft tissue sarcoma | PTEN protein | Tumors
leiomyosarcoma | RB1 | CGH | transcriptome | PTEN | undifferentiated sarcoma | DKK1 | CANCER-CENTERS-SARCOMA | MYOCARDIN | TRIO | CLASSIFICATION | PATHOLOGY | LEIOMYOSARCOMAS | TUMOR-NECROSIS-FACTOR | FRENCH-FEDERATION | MALIGNANT FIBROUS HISTIOCYTOMAS | ONCOLOGY | GENE-EXPRESSION | DIFFERENTIATION | PTEN Phosphohydrolase - genetics | Leiomyosarcoma - pathology | Genomics | Humans | Middle Aged | Intercellular Signaling Peptides and Proteins - genetics | Gene Expression Profiling - methods | Male | Comparative Genomic Hybridization - methods | Sarcoma - pathology | Cell Transformation, Neoplastic - genetics | Retinoblastoma Protein - genetics | Gene Deletion | Soft Tissue Neoplasms - pathology | Leiomyosarcoma - genetics | Adult | Female | Aged | Sarcoma - genetics | Soft Tissue Neoplasms - genetics | Cluster Analysis | Mesenchyme | Sarcoma | Wnt protein | Rhabdomyosarcoma | Data processing | Gene expression | Liposarcoma | genomics | Tumorigenesis | histiocytoma | Dkk1 protein | soft tissue sarcoma | PTEN protein | Tumors
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2017, Volume 23, Issue 3, pp. 857 - 867
Journal Article
Current Opinion in Oncology, ISSN 1040-8746, 07/2019, Volume 31, Issue 4, pp. 317 - 321
PURPOSE OF REVIEWLeiomyosarcoma (LMS) is among the more aggressive sarcomas and still suffers from the lack of efficient systemic treatment after, or before,...
LARGE SERIES | TARGET | PLACEBO | SOFT-TISSUE SARCOMAS | SUBTYPES | MTOR PATHWAY | smooth muscle | PATTERNS | leiomyosarcoma | IDENTIFIES 2 CLASSES | SMOOTH-MUSCLE DIFFERENTIATION | ONCOLOGY | chromosomal instability | genome sequencing | EXPRESSION | Usage | Gene mutations | Leiomyosarcoma | Genetic aspects | Nucleotide sequencing | Research | DNA sequencing
LARGE SERIES | TARGET | PLACEBO | SOFT-TISSUE SARCOMAS | SUBTYPES | MTOR PATHWAY | smooth muscle | PATTERNS | leiomyosarcoma | IDENTIFIES 2 CLASSES | SMOOTH-MUSCLE DIFFERENTIATION | ONCOLOGY | chromosomal instability | genome sequencing | EXPRESSION | Usage | Gene mutations | Leiomyosarcoma | Genetic aspects | Nucleotide sequencing | Research | DNA sequencing
Journal Article
American Journal of Pathology, The, ISSN 0002-9440, 2010, Volume 177, Issue 4, pp. 2080 - 2090
Alterations of the p53 pathway are among the most frequent aberrations observed in human cancers. We have performed an exhaustive analysis of TP53 , p14 , p15...
Pathology | MALIGNANT FIBROUS HISTIOCYTOMAS | TUMOR SUPPRESSION | LEIOMYOSARCOMA | GENES | MDM2 | INK4A/ARF LOCUS | MUTATIONS | PATHOLOGY | COMPARATIVE GENOMIC HYBRIDIZATION | P16(INK4A) | CANCER | Oligonucleotide Array Sequence Analysis | Signal Transduction | Tumor Suppressor Protein p53 - antagonists & inhibitors | Humans | RNA, Messenger - genetics | Tumor Suppressor Protein p53 - metabolism | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Gene Expression Profiling | Mutation - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Immunoenzyme Techniques | Tumor Suppressor Protein p53 - genetics | Sarcoma - metabolism | DNA Methylation | Comparative Genomic Hybridization | Cyclin-Dependent Kinase Inhibitor p15 - genetics | Gene Deletion | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Adult | Cyclin-Dependent Kinase Inhibitor p15 - metabolism | Sarcoma - genetics | Tumor Suppressor Protein p14ARF - genetics | Tumor Suppressor Protein p14ARF - metabolism | Regular
Pathology | MALIGNANT FIBROUS HISTIOCYTOMAS | TUMOR SUPPRESSION | LEIOMYOSARCOMA | GENES | MDM2 | INK4A/ARF LOCUS | MUTATIONS | PATHOLOGY | COMPARATIVE GENOMIC HYBRIDIZATION | P16(INK4A) | CANCER | Oligonucleotide Array Sequence Analysis | Signal Transduction | Tumor Suppressor Protein p53 - antagonists & inhibitors | Humans | RNA, Messenger - genetics | Tumor Suppressor Protein p53 - metabolism | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Gene Expression Profiling | Mutation - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Immunoenzyme Techniques | Tumor Suppressor Protein p53 - genetics | Sarcoma - metabolism | DNA Methylation | Comparative Genomic Hybridization | Cyclin-Dependent Kinase Inhibitor p15 - genetics | Gene Deletion | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Adult | Cyclin-Dependent Kinase Inhibitor p15 - metabolism | Sarcoma - genetics | Tumor Suppressor Protein p14ARF - genetics | Tumor Suppressor Protein p14ARF - metabolism | Regular
Journal Article
International Urology and Nephrology, ISSN 0301-1623, 8/2018, Volume 50, Issue 8, pp. 1449 - 1451
Journal Article